• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身磁共振成像在前列腺癌患者骨骼转移灶检测中的应用

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

作者信息

Venkitaraman R, Cook G J R, Dearnaley D P, Parker C C, Khoo V, Eeles R, Huddart R A, Horwich A, Sohaib S A

机构信息

Academic Uro-oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK.

出版信息

J Med Imaging Radiat Oncol. 2009 Jun;53(3):241-7. doi: 10.1111/j.1754-9485.2009.02070.x.

DOI:10.1111/j.1754-9485.2009.02070.x
PMID:19624290
Abstract

Whole-body MRI is an effective method for evaluating the entire skeletal system in patients with metastatic disease. This study aimed to compare whole-body MRI and radionuclide bone scintigraph in the detection of skeletal metastases in patients with prostate cancer. Patients with prostate cancer at high risk of skeletal metastasis with (i) prostate-specific antigen of > or =50 ng/mL; (ii) composite Gleason score of > or =8 with prostate-specific antigen of >20 ng/mL; or (iii) node-positive disease were enrolled in this prospective study before systemic treatment was initiated. Whole-body MR images and bone scans of 39 patients were analysed. Seven patients had bone metastases on bone scans, while seven patients had skeletal metastases by whole-body MRI, with concordant findings only in four patients. Compared with the 'gold standard', derived from clinical and radiological follow-up, the sensitivity for both bone scans and MRI was 70%, and the specificity for both was 100%. Magnetic resonance imaging detected 26 individual lesions compared with 18 lesions on bone scans. Only eight lesions were positive on both. Bone scans detected more rib metastases, while MRI identified more metastatic lesions in the spine. Whole-body MRI and radionuclide bone scintigraphy have similar specificity and sensitivity and may be used as complementary investigations to detect skeletal metastases from prostate cancer.

摘要

全身磁共振成像(MRI)是评估转移性疾病患者整个骨骼系统的有效方法。本研究旨在比较全身MRI和放射性核素骨扫描在检测前列腺癌患者骨转移方面的效果。具有以下情况之一的前列腺癌骨转移高危患者被纳入这项前瞻性研究:(i)前列腺特异性抗原≥50 ng/mL;(ii)Gleason评分≥8且前列腺特异性抗原>20 ng/mL;或(iii)淋巴结阳性疾病,在开始全身治疗之前入组。分析了39例患者的全身MR图像和骨扫描结果。7例患者骨扫描显示有骨转移,7例患者全身MRI显示有骨转移,仅4例患者结果一致。与临床和影像学随访得出的“金标准”相比,骨扫描和MRI的敏感性均为70%,特异性均为100%。磁共振成像检测到26个单独病灶,而骨扫描检测到18个病灶。两者均呈阳性的病灶仅8个。骨扫描检测到更多肋骨转移,而MRI发现脊柱的转移病灶更多。全身MRI和放射性核素骨扫描具有相似的特异性和敏感性,可作为检测前列腺癌骨转移的互补性检查方法。

相似文献

1
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.全身磁共振成像在前列腺癌患者骨骼转移灶检测中的应用
J Med Imaging Radiat Oncol. 2009 Jun;53(3):241-7. doi: 10.1111/j.1754-9485.2009.02070.x.
2
[Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].[前列腺癌骨转移的检测——全身MRI与骨闪烁显像的比较]
Rofo. 2008 Aug;180(8):746-52. doi: 10.1055/s-2008-1027479. Epub 2008 May 29.
3
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.全身磁共振弥散加权成像与骨扫描在前列腺癌或乳腺癌患者骨转移检测中的比较。
Skeletal Radiol. 2010 Apr;39(4):333-43. doi: 10.1007/s00256-009-0789-4.
4
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?18F-FDG PET/CT、99mTc-MDP 骨显像和全身 MRI 作为分期检查在检测骨肉瘤和尤文肉瘤患者骨转移中的比较能力如何?
Clin Orthop Relat Res. 2021 Aug 1;479(8):1768-1779. doi: 10.1097/CORR.0000000000001681.
5
Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.与平面骨闪烁显像相比,单光子发射计算机断层扫描(SPECT)及SPECT/低剂量计算机断层扫描在检测晚期乳腺癌骨转移方面并未提高敏感性或特异性。
Clin Physiol Funct Imaging. 2016 Jan;36(1):40-6. doi: 10.1111/cpf.12191. Epub 2014 Sep 26.
6
Computer-assisted interpretation of planar whole-body bone scans.平面全身骨扫描的计算机辅助解读。
J Nucl Med. 2008 Dec;49(12):1958-65. doi: 10.2967/jnumed.108.055061. Epub 2008 Nov 7.
7
Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.用于检测转移性骨肿瘤的全身磁共振成像:与骨闪烁显像的比较
Magn Reson Med Sci. 2005;4(1):11-7. doi: 10.2463/mrms.4.11.
8
Ga-PSMA-PET/CT in comparison with F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.镓-PSMA-PET/CT 与 F-氟代脱氧葡萄糖-PET/CT 和全身 MRI 比较在前列腺癌患者骨转移检测中的前瞻性诊断准确性研究。
Eur Radiol. 2019 Mar;29(3):1221-1230. doi: 10.1007/s00330-018-5682-x. Epub 2018 Aug 21.
9
Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.全身 3D T1 加权磁共振成像在前列腺癌患者中的应用:在筛查转移性疾病中的可行性和评估。
Radiology. 2015 Apr;275(1):155-66. doi: 10.1148/radiol.14141242. Epub 2014 Dec 15.
10
Role of whole-body diffusion-weighted MRI in detecting bone metastasis.全身弥散加权 MRI 在骨转移检测中的作用。
Radiol Med. 2014 Oct;119(10):758-66. doi: 10.1007/s11547-014-0395-y. Epub 2014 Mar 18.

引用本文的文献

1
Imaging of Bone Metastases in Breast Cancer.乳腺癌骨转移的影像学表现。
Semin Nucl Med. 2022 Sep;52(5):531-541. doi: 10.1053/j.semnuclmed.2022.01.005. Epub 2022 Feb 27.
2
Whole-body MRI: detecting bone metastases from prostate cancer.全身 MRI:检测前列腺癌的骨转移。
Jpn J Radiol. 2022 Mar;40(3):229-244. doi: 10.1007/s11604-021-01205-6. Epub 2021 Oct 25.
3
Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies.PET/CT与MRI在前列腺癌患者骨转移诊断中的比较:诊断研究的网络分析
Front Oncol. 2021 Oct 4;11:736654. doi: 10.3389/fonc.2021.736654. eCollection 2021.
4
A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer.局部非转移性放射性复发性前列腺癌挽救性局部治疗的系统评价
Transl Androl Urol. 2020 Jun;9(3):1535-1545. doi: 10.21037/tau.2019.08.21.
5
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.PSMA-PET/CT、胆碱-PET/CT、NaF-PET/CT、MRI 和骨闪烁显像在前列腺癌患者骨转移诊断中的比较:系统评价和荟萃分析。
Skeletal Radiol. 2019 Dec;48(12):1915-1924. doi: 10.1007/s00256-019-03230-z. Epub 2019 May 24.
6
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.多参数全身 3.0-T MRI 在新诊断的中高危前列腺癌中的应用:用于淋巴结和转移分期的诊断准确性和观察者间一致性。
Eur Radiol. 2019 Jun;29(6):3159-3169. doi: 10.1007/s00330-018-5813-4. Epub 2018 Dec 5.
7
Imaging of distant metastases of prostate cancer.前列腺癌远处转移的影像学表现。
Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2.
8
Imaging modalities in synchronous oligometastatic prostate cancer.同步寡转移前列腺癌的影像学方法。
World J Urol. 2019 Dec;37(12):2573-2583. doi: 10.1007/s00345-018-2416-2. Epub 2018 Aug 1.
9
Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?T1 加权和弥散加权磁共振成像在前列腺癌椎体转移随访中比骨闪烁扫描有附加价值吗?
Investig Clin Urol. 2017 Sep;58(5):324-330. doi: 10.4111/icu.2017.58.5.324. Epub 2017 Aug 3.
10
Detecting Tumor Metastases: The Road to Therapy Starts Here.检测肿瘤转移:治疗之路始于此。
Adv Cancer Res. 2016;132:1-44. doi: 10.1016/bs.acr.2016.07.001. Epub 2016 Aug 17.